Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
19.54
+0.44 (2.30%)
Mar 23, 2026, 3:10 PM EDT - Market open

KMTS Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTMFY 2025FY 2023FY 2022FY 2020FY 2019
Period Ending
Jan '26 Apr '25 Apr '24 Apr '23 Apr '21 Apr '20
83.7259.8227.817.63--
Revenue Growth (YoY)
59.06%115.05%264.54%---
Cost of Revenue
42.9135.6127.4518.28--
Gross Profit
40.8124.210.36-10.65--
Selling, General & Admin
165.19114.9469.9454.0113.96.52
Research & Development
19.2415.6515.4915.7618.8122.8
Total Operating Expenses
184.42130.5985.4369.7732.7129.32
Operating Income
-143.61-106.38-85.06-80.42-32.71-29.32
Interest Income
7.783.2----
Interest Expense
-7.46-7.73-6.23-5.63-1.17-
Other Non-Operating Income (Expense)
-0.4-2.77-2.81.83-0.04-
Total Non-Operating Income (Expense)
-0.07-7.3-9.03-3.8-1.21-
Pretax Income
-143.68-113.68-94.1-84.22-33.91-29.32
Provision for Income Taxes
0.20.140.020.020.190.15
Net Income
-147.18-126.14-100.84-86.74-34.1-29.47
Net Income Attributable to Preferred Dividends
3.2912.326.722.5--
Net Income to Common
-147.18-126.14-100.84-86.74-34.1-29.47
Shares Outstanding (Basic)
4625200--
Shares Outstanding (Diluted)
4625200--
Shares Change (YoY)
130.21%23.63%18693.84%---
EPS (Basic)
-3.96-5.13-5.07-820.00--
EPS (Diluted)
-3.96-5.13-5.07-820.00--
Free Cash Flow
--100.54-84.46-69.64-30.23-30.53
Free Cash Flow Per Share
--4.09-4.25-658.19--
Gross Margin
48.75%40.47%1.30%-139.59%--
Operating Margin
-171.53%-177.85%-305.83%-1054.01%--
Profit Margin
-171.87%-190.28%-338.39%-1104.04%--
FCF Margin
--168.09%-303.66%-912.74%--
EBITDA
-143.61-98.41-73.5-80.42-32.29-28.84
EBITDA Margin
-171.53%-164.52%-264.27%-1054.01%--
EBIT
-143.61-106.38-85.06-80.42-32.71-29.32
EBIT Margin
-171.53%-177.85%-305.83%-1054.01%--
Effective Tax Rate
-0.14%-0.12%-0.03%-0.02%-0.55%-0.50%
Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q